AdvaMed® Responds to Congressional RFI on AI in Health Care
This week, AdvaMed®, the Medtech Association, responded to a request for information from Congressman Ami Bera regarding the use of artificial intelligence (AI) in health care.
Press Releases
Your source for the latest medtech news from AdvaMed® and our members.
Filter By:
Integrity Orthopaedics Announces Closure Of Series B Financing
Integrity Orthopaedics, Inc., a company pioneering next generation solutions for soft tissue repair, has successfully closed on a Series B financing of $20.6 million.
AdvaMed® Statement on the Release of FDA Rule on Laboratory-Developed Tests
Today, AdvaMed®, the Medtech Association, released the following statements from President and CEO Scott Whitaker and Zach Rothstein, Executive Director of AdvaMedDx®, on FDA’s final rule for Laboratory Developed Tests (LDTs):
New Episode of Medtech POV Podcast: Nanowear CEO Venk Varadan Details Medtech Startup Journey, Regulatory Pathway, and Payment Hurdles Facing Industry
The newest episode of Medtech POV with Scott Whitaker, out today on all podcast streaming platforms, highlights Venk Varadan’s journey as a medtech entrepreneur. Varadan, CEO and co-founder of Nanowear,…
Press Contacts
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 206-225-5226
AdvaMed® Urges Senate Leader to Prioritize R&D Tax Credit in Any Tax Package
This week, in a letter to Senate Majority Leader Chuck Schumer, AdvaMed® President and CEO Scott Whitaker underscored the critical importance of passing a tax provision that allows small businesses…
AdvaMed® Statement on FDA-USAID India Regulatory Session
AdvaMed®, the Medtech Association, released the following statement thanking the FDA Center for Radiological Health (CDRH) for recently hosting an event in New Delhi to discuss regulatory policies and best practices for ensuring…
Nectero Medical Announces Completion of $96M Series D Financing
Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, today announced the closing of its $96 million Series D financing round. Financing was led by Norwest Venture…
AdvaMed® to CMS: “1,138 Days Without Breakthrough Coverage is Harming Seniors”
AdvaMed®, the Medtech Association, unveiled a timer on the organization’s website to track the number of days since the Centers for Medicare and Medicaid Services (CMS) ended the coverage pathway…
Listen to AdvaMed®'s Podcast
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease
PhotoPharmics, a pioneer in specialized phototherapy for neurodegenerative diseases, alongside the Center for Health + Technology (CHeT) at the University of Rochester Medical Center (URMC), today announced the initiation of…